| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 1.85B | — |
| Operating expense | — | — |
| Net income | -2.59B | 147.02% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 9606.HK returned -44.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -36.8% |
| 1 year | -44.6% |
| All-time high | $363.60 (Sep 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 9606.HK would be worth today ›No. Duality Biotherapeutics, Inc. has not paid a dividend in the past 12 months.
Duality Biotherapeutics, Inc. is part of the Healthcare sector.
Duality Biotherapeutics, Inc. has a market cap of 17.15B HKD, based on the latest quote.